UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 105

Sortiert nach

Silencing of the VHL Tumor-Suppressor Gene by DNA Methylation in Renal Carcinoma

Proceedings of the National Academy of Sciences - PNAS, 1994-10, Vol.91 (21), p.9700-9704

1994

Volltextzugriff (PDF)

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer

Clinical cancer research, 1996-03, Vol.2 (3), p.483-491

1996

Volltextzugriff (PDF)

Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-Aza-2'-deoxycytidine

Cancer research (Chicago, Ill.), 1994-04, Vol.54 (7), p.1766-1771

1994

Volltextzugriff (PDF)

Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial

Molecular and Cellular Biology, 1995-11, Vol.15 (11), p.6150-6159

1995

Volltextzugriff (PDF)

Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells

Clinical cancer research, 1997-10, Vol.3 (10), p.1755-1762

1997

Volltextzugriff (PDF)

Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs

Biochemical pharmacology, 1996-08, Vol.52 (4), p.659-667

1996

Volltextzugriff (PDF)

Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells : structure-function analysis

Leukemia, 1999-08, Vol.13 (8), p.1243-1253

1999

Volltextzugriff (PDF)

Re: Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase

JNCI : Journal of the National Cancer Institute, 1999-03, Vol.91 (5), p.475

Samid, D

1999

Volltextzugriff (PDF)

Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells

Biochimica et biophysica acta, 2005-05, Vol.1734 (1), p.1-12

2005

Volltextzugriff (PDF)

Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate

Journal of neurosurgery, 1995-10, Vol.83 (4), p.672

1995

Volltextzugriff (PDF)

Capecitabine Plus Paclitaxel As Front-Line Combination Therapy for Metastatic Breast Cancer: A Multicenter Phase II Study

Journal of clinical oncology, 2004-06, Vol.22 (12), p.2321-2327

2004

Volltextzugriff (PDF)

Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers

Advances in experimental medicine and biology, 1997, Vol.400A, p.501

1997

Volltextzugriff (PDF)

Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate

Clinical cancer research, 1996-05, Vol.2 (5), p.865-872

1996

Volltextzugriff (PDF)

Modulation of radiation response of human tumour cells by the differentiation inducers, phenylacetate and phenylbutyrate

International journal of radiation biology, 1997-08, Vol.72 (2), p.211-218

1997

Volltextzugriff (PDF)

Disposition of Phenylbutyrate and its Metabolites, Phenylacetate and Phenylacetylglutamine

Journal of clinical pharmacology, 1995-04, Vol.35 (4), p.368-373

1995

Volltextzugriff (PDF)

Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene

Molecular pharmacology, 1996-06, Vol.49 (6), p.972

1996

Volltextzugriff (PDF)

Phase II Study of Capecitabine in Patients With Fluorouracil-Resistant Metastatic Colorectal Carcinoma

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2078-2083

2004

Volltextzugriff (PDF)

Phenylacetate in chemoprevention: in vitro and in vivo suppression of 5-aza-2'-deoxycytidine-induced carcinogenesis

Clinical cancer research, 1995-08, Vol.1 (8), p.865-871

1995

Volltextzugriff (PDF)

Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine

Molecular and Cellular Biology, 1987-06, Vol.7 (6), p.2196-2200

1987

Volltextzugriff (PDF)

Lipid Metabolism as a Target for Brain Cancer Therapy: Synergistic Activity of Lovastatin and Sodium Phenylacetate Against Human Glioma Cells

Journal of neurochemistry, 1996-02, Vol.66 (2), p.710-716

1996

Volltextzugriff (PDF)

Phenylacetate is an Inhibitor of Prostatic Growth and Development in Organ Culture

The Journal of urology, 1996-05, Vol.155 (5), p.1762-1770

1996

Volltextzugriff (PDF)

Tumor radiosensitization based on the use of inhibitors of the mevalonate pathway of cholesterol synthesis

Advances in experimental medicine and biology, 1997, Vol.400B, p.825

1997

Volltextzugriff (PDF)

Review: molecular biology of transgenic animals

Journal of animal science, 1993, Vol.71 Suppl 3, p.1

1993

Volltextzugriff (PDF)

Posttranscriptional down-regulation of ras oncogene expression by inhibitors of cellular glutathione

Molecular and Cellular Biology, 1993-07, Vol.13 (7), p.4416-4422

1993

Volltextzugriff (PDF)

Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression

Radiation research, 1991-05, Vol.126 (2), p.244

1991

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Humans
(60)
Life Sciences & Biomedicine
(56)
Biological And Medical Sciences
(44)
Medical Sciences
(32)
Animals
(30)
Oncology
(26)
Pharmacology. Drug Treatments
(26)
Phenylacetates - Pharmacology
(24)
Mice
(23)
Antineoplastic Agents
(21)
Cell Division - Drug Effects
(21)
Tumor Cells, Cultured
(21)
Female
(17)
Male
(16)
Cell Line
(15)
Phenylbutyrates - Pharmacology
(14)
Fundamental And Applied Biological Sciences. Psychology
(12)
Adult
(11)
Cell Differentiation - Drug Effects
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Silencing of the VHL Tumor-Suppressor Gene by DNA Methylation in Renal Carcinoma

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer

Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-Aza-2'-deoxycytidine

Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial

Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells

Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs

Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells : structure-function analysis

Re: Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase

Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells

Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate

Capecitabine Plus Paclitaxel As Front-Line Combination Therapy for Metastatic Breast Cancer: A Multicenter Phase II Study

Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers

Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate

Modulation of radiation response of human tumour cells by the differentiation inducers, phenylacetate and phenylbutyrate

Disposition of Phenylbutyrate and its Metabolites, Phenylacetate and Phenylacetylglutamine

Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene

Phase II Study of Capecitabine in Patients With Fluorouracil-Resistant Metastatic Colorectal Carcinoma

Phenylacetate in chemoprevention: in vitro and in vivo suppression of 5-aza-2'-deoxycytidine-induced carcinogenesis

Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine

Lipid Metabolism as a Target for Brain Cancer Therapy: Synergistic Activity of Lovastatin and Sodium Phenylacetate Against Human Glioma Cells

Phenylacetate is an Inhibitor of Prostatic Growth and Development in Organ Culture

Tumor radiosensitization based on the use of inhibitors of the mevalonate pathway of cholesterol synthesis

Review: molecular biology of transgenic animals

Posttranscriptional down-regulation of ras oncogene expression by inhibitors of cellular glutathione

Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression

Suchergebnisse filtern